Renal Cancers Recruiting Phase 1 Trials for Durvalumab (DB11714)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02762006Neoadjuvant MEDI 4736 +/- Tremelimumab in Locally Advanced Renal Cell CarcinomaTreatment